- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04989569
Serial Body Composition Change for Risk Prediction and Nutritional Guide in Treating Patients With Sepsis
August 31, 2023 updated by: Chang Gung Memorial Hospital
To explore whether serial changes of data in body composition of patients with sepsis can help clinician to monitor prognosis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators will use the random number generator to divide the patients into two groups, the control group (with no nutritional intervention) and the intervention group (with nutritional intervention).
The body composition data (of day 1, 3, 8) of the patients in the intervention group will be given to the dietitians for adjusting the diet formula according to the patient's body composition.The patients in control group also will undergo Bio-electrical Impedance Analysis (BIA) assessment, but not disclosed to the dietitian.
The diet formula will be adjusted on the discretion of the dietitian caring for the septic patients based on clinical judgement.
Study Type
Interventional
Enrollment (Actual)
132
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: HUNG KAI-YIN
- Phone Number: 8775 +886 7 731 7123
- Email: redrosahung@cgmh.org.tw
Study Contact Backup
- Name: FANG WEN-FENG
- Phone Number: 8775 +886 7 731 7123
- Email: wenfengfang@yahoo.com.tw
Study Locations
-
-
-
Kaohsiung City, Taiwan, 83301
- Kaohsiung Chang Gung Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- ICU patient
- Clinical diagnosis of sepsis
Exclusion Criteria:
1. Expired within 3-days
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: control
The investigators will use the random number generator to divide the patients into two groups, the control group (with no nutritional intervention) and the intervention group (with nutritional intervention).
The body composition data (of day 1, 3, 8) of the patients in the control group will not be given to the dietitians for adjusting the diet formula according to the patient's body composition.
|
|
Experimental: nutritional intervention
The investigators will use the random number generator to divide the patients into two groups, the control group (with no nutritional intervention) and the intervention group (with nutritional intervention).
The body composition data (of day 1, 3, 8) of the patients in the intervention group will be given to the dietitians for adjusting the diet formula according to the patient's body composition.
|
In the intervention group, the body composition data (of day 1, 3, 8) will be given to the dietitians for adjusting the diet formula.
The diet formula will be adjusted on the discretion of the dietitian caring for the septic patients based on clinical judgement.
The policy adopted by the dietary treatment guidelines for sepsis is to adjust the dietary concentration when there is too much extracellular water under the premise of gastrointestinal tolerance.
When the skeletal muscle mass loss is too fast, the dietitians will increase the protein intake by 1.2g/kg of body weight.
For patients with acute renal failure and excess extracellular water accumulation and muscle loss, the dietitians will adjust the protein, sodium, potassium, calcium and phosphorus content in the formula.
The dietitians will give appropriate nutrition prescriptions based on clinical signs, disease diagnosis and biochemical values.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ICU mortality
Time Frame: The day discharged from ICU, an average of 2 weeks
|
Status of survival or mortality at the time discharged from ICU
|
The day discharged from ICU, an average of 2 weeks
|
Hospital mortality
Time Frame: The day discharged from hospital, an average of 5 weeks
|
Status of survival or mortality at the time discharged from hospital
|
The day discharged from hospital, an average of 5 weeks
|
7-day mortality
Time Frame: Day 7 after hospital admission
|
Status of survival or mortality at Day 7 during hospital stay
|
Day 7 after hospital admission
|
28-day mortality
Time Frame: Day 28 after hospital admission
|
Status of survival or mortality at Day 28 during hospital stay
|
Day 28 after hospital admission
|
90-day mortality
Time Frame: Day 90 after hospital admission
|
Status of survival or mortality at Day 90 during hospital stay
|
Day 90 after hospital admission
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of white blood cell between day 1 and day 3
Time Frame: Day 1 and Day 3 after ICU admission
|
assessing the change of white blood cell count between day 1 and day 3
|
Day 1 and Day 3 after ICU admission
|
Change of white blood cell between day 1 and day 8
Time Frame: Day 1 and Day8 after ICU admission
|
assessing the change of white blood cell count between day 1 and day 8
|
Day 1 and Day8 after ICU admission
|
Change of white blood cell between day 3 and day 8
Time Frame: Day 3 and Day 8 after ICU admission
|
assessing the change of white blood cell count between day 3 and day 8
|
Day 3 and Day 8 after ICU admission
|
Change of pulse pressure between day 1 and day 3
Time Frame: Day 1 and Day 3 after ICU admission
|
assessing the change of pulse pressure between day 1 and day 3
|
Day 1 and Day 3 after ICU admission
|
Change of pulse pressure between day 1 and day 8
Time Frame: Day 1 and Day 8 after ICU admission
|
assessing the change of pulse pressure between day 1 and day 8
|
Day 1 and Day 8 after ICU admission
|
Change of pulse pressure between day 3 and day 8
Time Frame: Day 3 and Day 8 after ICU admission
|
assessing the change of pulse pressure between day 3 and day 8
|
Day 3 and Day 8 after ICU admission
|
Day 1 Sequential Organ Failure Assessment score
Time Frame: Day 1 after ICU admission
|
assessing Sequential Organ Failure Assessment score at day 1
|
Day 1 after ICU admission
|
Day 3 Sequential Organ Failure Assessment score
Time Frame: Day 3 after ICU admission
|
assessing Sequential Organ Failure Assessment score at day 3
|
Day 3 after ICU admission
|
Day 8 Sequential Organ Failure Assessment score
Time Frame: Day 8 after ICU admission
|
assessing Sequential Organ Failure Assessment score at day 8
|
Day 8 after ICU admission
|
Ventilation days
Time Frame: The day weaned off ventilator, an average of 3 weeks
|
Total using days of mechanical ventilation
|
The day weaned off ventilator, an average of 3 weeks
|
Change of percentage of body fat between day 1 and day 3
Time Frame: Day 1 and Day 3 after ICU admission
|
assessing the change of percentage of body fat between day 1 and day 3
|
Day 1 and Day 3 after ICU admission
|
Change of percentage of body fat between day 1 and day 8
Time Frame: Day 1 and Day 8 after ICU admission
|
assessing the change of percentage of body fat between day 1 and day 8
|
Day 1 and Day 8 after ICU admission
|
Change of percentage of body fat between day 3 and day 8
Time Frame: Day 3 and Day 8 after ICU admission
|
assessing the change of percentage of body fat between day 3 and day 8
|
Day 3 and Day 8 after ICU admission
|
Change of protein intake between day 1 and day 3
Time Frame: Day 1 and Day 3 after ICU admission
|
assessing the change of protein intake (g/day, g/kg) between day 1 and day 3
|
Day 1 and Day 3 after ICU admission
|
Change of protein intake between day 1 and day 8
Time Frame: Day 1 and Day 8 after ICU admission
|
assessing the change of protein intake (g/day, g/kg) between day 1 and day 8
|
Day 1 and Day 8 after ICU admission
|
Change of protein intake between day 3 and day 8
Time Frame: Day 3 and Day 8 after ICU admission
|
assessing the change of protein intake (g/day, g/kg) between day 3 and day 8
|
Day 3 and Day 8 after ICU admission
|
Change of energy intake between day 1 and day 3
Time Frame: Day 1 and Day 3 after ICU admission
|
assessing the change of energy intake (total kcal/day) between day 1 and day 3
|
Day 1 and Day 3 after ICU admission
|
Change of energy intake between day 1 and day 8
Time Frame: Day 1 and Day 8 after ICU admission
|
assessing the change of energy intake (total kcal/day) between day 1 and day 8
|
Day 1 and Day 8 after ICU admission
|
Change of energy intake between day 3 and day 8
Time Frame: Day 3 and Day 8 after ICU admission
|
assessing the change of energy intake (total kcal/day) between day 3 and day 8
|
Day 3 and Day 8 after ICU admission
|
Change of segment/monocyte ratio between day 1 and day 3
Time Frame: Day 1 and Day 3 after ICU admission
|
assessing the change of segment count to monocyte count ratio between day 1 and day 3
|
Day 1 and Day 3 after ICU admission
|
Change of segment/monocyte ratio between day 1 and day 8
Time Frame: Day 1 and Day 8 after ICU admission
|
assessing the change of segment count to monocyte count ratio between day 1 and day 8
|
Day 1 and Day 8 after ICU admission
|
Change of segment/monocyte ratio between day 3 and day 8
Time Frame: Day 3 and Day 8 after ICU admission
|
assessing the change of segment count to monocyte count ratio between day 3 and day 8
|
Day 3 and Day 8 after ICU admission
|
Change of total body water between day 1 and day 3
Time Frame: Day 1 and Day 3 after ICU admission
|
assessing the change of total body water between day 1 and day 3
|
Day 1 and Day 3 after ICU admission
|
Change of total body water between day 1 and day 8
Time Frame: Day 1 and Day 8 after ICU admission
|
assessing the change of total body water between day 1 and day 8
|
Day 1 and Day 8 after ICU admission
|
Change of total body water between day 3 and day 8
Time Frame: Day 3 and Day 8 after ICU admission
|
assessing the change of total body water between day 3 and day 8
|
Day 3 and Day 8 after ICU admission
|
Change of soft lean mass between day 1 and day 3
Time Frame: Day 1 and Day 3 after ICU admission
|
assessing the change of soft lean mass between day 1 and day 3
|
Day 1 and Day 3 after ICU admission
|
Change of soft lean mass between day 1 and day 8
Time Frame: Day 1 and Day 8 after ICU admission
|
assessing the change of soft lean mass between day 1 and day 8
|
Day 1 and Day 8 after ICU admission
|
Change of soft lean mass between day 3 and day 8
Time Frame: Day 3 and Day 8 after ICU admission
|
assessing the change of soft lean mass between day 3 and day 8
|
Day 3 and Day 8 after ICU admission
|
ICU Days
Time Frame: The day discharged from ICU, an average of 2 weeks
|
length of ICU stay
|
The day discharged from ICU, an average of 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: FANG WEN-FENG, Chang Gung memorial hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2020
Primary Completion (Actual)
March 19, 2023
Study Completion (Actual)
April 28, 2023
Study Registration Dates
First Submitted
July 1, 2021
First Submitted That Met QC Criteria
July 29, 2021
First Posted (Actual)
August 4, 2021
Study Record Updates
Last Update Posted (Actual)
September 1, 2023
Last Update Submitted That Met QC Criteria
August 31, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201901875A3C501
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityRecruitingSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
Zagazig UniversityRecruitingSepsis-associated EncephalopathyEgypt
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); New York Presbyterian Hospital and other collaboratorsCompletedSepsis | Septic Shock | Severe Sepsis | Infection | Sepsis SyndromeUnited States
Clinical Trials on Nutritional intervention
-
Clinica Universidad de Navarra, Universidad de...Recruiting
-
China-Japan Friendship HospitalRecruiting
-
HAN University of Applied SciencesFrieslandCampina; HAS Hogeschool; Centre of Expertise Food (CoE Food); SligroCompletedMalnutrition; Protein | Protein MalnutritionNetherlands
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedObesity | OverweightUnited States
-
Gødstrup HospitalDanish Cancer SocietyNot yet recruitingCancer | Malnutrition | Nutritional InterventionDenmark
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR); Laval UniversityRecruitingPregnancy Complications | Gestational DiabetesCanada
-
Johannes Gutenberg University MainzGoethe UniversityCompletedDiabetes Mellitus, Type 2 | Hyperlipidemias | NASH - Nonalcoholic SteatohepatitisGermany
-
Hospices Civils de LyonCompleted
-
University of ZurichCompletedHealthy ControlsSwitzerland